anonymous
Guest
anonymous
Guest
Will be interesting to see. Safety is a big concern with compounded topical jaks and it is not a commonly compounded drug. What do compounding pharmacies charge anyway?
yes, I asked three of my key current targets in my territory about this drug during my research phase, to see if this was really an opportunity I wanted to pursue. They all said the same, “not much need for said product, can already be compounded, safety issues” etc. It’s funny because the DM tried to sell me on the opportunity based on the fact that the topical JAK had ZERO safety concerns!!! This was after said “DM” (who looked 14) asked me “what my secret sauce” was in an interview. You’ve got to be kidding!? I happily declined the offer! Wasn’t for me! I wish everyone luck!